Bausch + Lomb Cash Flow from Operating Activities 2021-2024 | BLCO
Bausch + Lomb annual/quarterly cash flow from operating activities history and growth rate from 2021 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Bausch + Lomb cash flow from operating activities for the quarter ending March 31, 2024 was $0.041B, a 173.21% decline year-over-year.
- Bausch + Lomb cash flow from operating activities for the twelve months ending March 31, 2024 was $-88M, a 113.88% decline year-over-year.
- Bausch + Lomb annual cash flow from operating activities for 2023 was $-0.017B, a 104.93% decline from 2022.
- Bausch + Lomb annual cash flow from operating activities for 2022 was $0.345B, a 60.48% decline from 2021.
- Bausch + Lomb annual cash flow from operating activities for 2021 was $0.873B, a 67.24% increase from 2020.
| Bausch + Lomb Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2023 | $-17 |
| 2022 | $345 |
| 2021 | $873 |
| 2020 | $522 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.410B | $4.146B |
| Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $117.915B | 14.80 |
| Cencora (COR) | United States | $43.985B | 17.15 |
| ICON (ICLR) | Ireland | $26.639B | 25.15 |
| DiDi Global (DIDIY) | China | $22.358B | 0.00 |
| Avantor (AVTR) | United States | $16.031B | 23.60 |
| CochLear (CHEOY) | Australia | $13.625B | 0.00 |
| Natera (NTRA) | United States | $13.523B | 0.00 |
| Revvity (RVTY) | United States | $13.368B | 23.45 |
| Viatris (VTRS) | United States | $12.478B | 3.73 |
| Medpace Holdings (MEDP) | United States | $11.950B | 39.32 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.358B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.803B | 20.68 |
| Solventum (SOLV) | United States | $10.078B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.710B | 0.00 |
| HealthEquity (HQY) | United States | $6.884B | 50.72 |
| Organon (OGN) | United States | $5.385B | 5.11 |
| Doximity (DOCS) | United States | $5.177B | 36.04 |
| PACS (PACS) | United States | $4.499B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.467B | 31.72 |
| Life Times (LTH) | United States | $3.279B | 34.35 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| GoodRx Holdings (GDRX) | United States | $2.837B | 108.00 |
| Agilon Health (AGL) | United States | $2.566B | 0.00 |
| Progyny (PGNY) | United States | $2.535B | 43.64 |
| NovoCure (NVCR) | Jersey | $2.397B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.064B | 8.18 |
| Premier (PINC) | United States | $1.985B | 8.49 |
| BrightSpring Health Services (BTSG) | United States | $1.962B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.915B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.507B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.420B | 0.00 | |
| Embecta (EMBC) | United States | $0.717B | 4.87 |
| CareDx (CDNA) | United States | $0.704B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.645B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.619B | 6.57 |
| InnovAge Holding (INNV) | United States | $0.589B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| GeneDx Holdings (WGS) | United States | $0.533B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.507B | 0.00 |
| Enhabit (EHAB) | United States | $0.461B | 46.00 |
| ModivCare (MODV) | United States | $0.403B | 7.54 |
| Sonida Senior Living (SNDA) | United States | $0.383B | 0.00 |
| LifeMD (LFMD) | United States | $0.359B | 0.00 |
| MultiPlan (MPLN) | United States | $0.348B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.324B | 0.00 |
| Sharecare (SHCR) | United States | $0.306B | 0.00 |
| DocGo (DCGO) | United States | $0.300B | 16.39 |
| Beauty Health (SKIN) | United States | $0.270B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.223B | 0.00 |
| Biodesix (BDSX) | United States | $0.155B | 0.00 |
| So-Young (SY) | China | $0.104B | 52.50 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.71 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Oncology Institute (TOI) | United States | $0.035B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| DermTech (DMTK) | United States | $0.011B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| OpGen (OPGN) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |